On Thursday, Pediatrix Medical earned a positive adjustment to its Relative Strength (RS) Rating, from 69 to 80.
Looking For The Best Stocks To Buy And Watch? Start Here
IBD's proprietary RS Rating measures technical performance by using a 1 (worst) to 99 (best) score that shows how a stock's price performance over the trailing 52 weeks matches up against that of all other stocks.
History shows that the stocks that go on to make the biggest gains often have an RS Rating of over 80 as they launch their biggest climbs.
Pediatrix Medical is working on a cup without handle with a 17.67 entry. See if the stock can clear the breakout price in heavy trading.
The company showed 56% EPS growth last quarter, while sales growth came in at -7%.
The company holds the No. 4 rank among its peers in the Medical-Outpatient/Home Care industry group. Encompass Health is the No. 1-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Improved Technical Action?
